Yes. JYNNEOS is the name of the FDA-approved monkeypox vaccine - it is two doses, administered 28 days apart. Full protection begins two weeks after the second shot. The monkeypox vaccine is FDA approved and available at no cost to the individual.
Given how little vaccine we have received, our top priority for vaccination remains people with known exposures to monkeypox patients. There are two groups currently eligible for monkeypox vaccine: (1) individuals with known exposures as well as (2) individuals with likely high-risk exposures in the last 14 days.
Known exposures are identified via contact tracing. The second group was determined based on best practices identified in other jurisdictions as well as limited data collected regarding Louisiana's monkeypox cases to date.
Specifically, this second group includes: Gay, bisexual, other (cis or trans) men who have sex with men OR Transgender women and nonbinary persons assigned male at birth who have sex with men and
- Have had intimate or sexual contact with multiple or anonymous partners in last 14 days OR
- Have had intimate or sexual contact with other men in a social or sexual venue in the last 14 days
OR Individuals (of any sex/gender identity) who have given or received money or other goods/services in exchange for sex in the last 14 days
It is a high priority to provide vaccine pre-exposure to at-risk individuals; we are actively advocating CDC for sufficient allocations to be able to do so.
Important note: Anyone can contract monkeypox and the current eligibility criteria are only limited to the above groups because they are most at risk based on the first diagnoses we have seen. However, the criteria will be expanded as additional vaccine becomes available and/or individuals from other groups are diagnosed.
Here is a list of all locations in Louisiana that have received monkeypox vaccine. We recommend you call ahead.